|
|
Volumn 27, Issue 2, 2009, Pages 108-109
|
|
Avastin-Tarceva combination fails in lung cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMG 386;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CAPECITABINE;
CETUXIMAB;
ERLOTINIB;
FLUOROURACIL;
FOLINIC ACID;
OXALIPLATIN;
PANITUMUMAB;
PLACEBO;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
BREAST CANCER;
CANCER CELL;
CANCER GROWTH;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG EFFICACY;
HUMAN;
LUNG CANCER;
LUNG NON SMALL CELL CANCER;
METASTASIS;
MUTATION;
NOTE;
ONCOGENE K RAS;
OVARY CANCER;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS AS TOPIC;
DRUG THERAPY, COMBINATION;
HUMANS;
NEOPLASMS;
QUINAZOLINES;
|
|
EID: 59849105332
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0209-108 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|
